TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia
Publication
, Conference
Ware, RE; Davis, BR; Schultz, WH; Brown, C; Aygun, B; Sarnaik, SA; Odame, I; Fuh, B; George, A; Owen, W; Luchtman-Jones, L; Rogers, ZR ...
Published in: BLOOD
December 3, 2015
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 3, 2015
Volume
126
Issue
23
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
57th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, C., Aygun, B., Sarnaik, S. A., … Adams, R. J. (2015). TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia. In BLOOD (Vol. 126). Orlando, FL: AMER SOC HEMATOLOGY.
Ware, Russell E., Barry R. Davis, William H. Schultz, Clark Brown, Banu Aygun, Sharada A. Sarnaik, Isaac Odame, et al. “TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia.” In BLOOD, Vol. 126. AMER SOC HEMATOLOGY, 2015.
Ware RE, Davis BR, Schultz WH, Brown C, Aygun B, Sarnaik SA, et al. TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia. In: BLOOD. AMER SOC HEMATOLOGY; 2015.
Ware, Russell E., et al. “TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia.” BLOOD, vol. 126, no. 23, AMER SOC HEMATOLOGY, 2015.
Ware RE, Davis BR, Schultz WH, Brown C, Aygun B, Sarnaik SA, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone CM, Lee MT, Kwiatkowski J, Jackson S, Miller ST, Roberts CW, Heeney MM, Kalfa TA, Nelson SC, Imran H, Nottage KA, Alvarez OA, Rhodes M, Thompson AA, Rothman J, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood JC, Piller L, Wei P, Luden J, Mortier NA, Stuber S, Luban NLC, Cohen AR, Pressel SL, Adams RJ. TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia. BLOOD. AMER SOC HEMATOLOGY; 2015.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 3, 2015
Volume
126
Issue
23
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
57th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology